Oral Abstract Session:
125. Fungal Infections
Friday, October 5, 2018: 10:30 AM-11:45 AM
Room: W 2002

Tracks: Pediatric ID, HIV-STD-TB, Epidemiology and Infection Control, Adult ID

Moderators:  Kimberly E. Hanson, MD, MHS, University of Utah School of Medicine and Jeniel Nett, MD, PhD, University of Wisconsin, Madison

10:30 AM
Inhibition of host neuraminidase increases susceptibility to invasive pulmonary aspergillosis
Frank Van De Veerdonk Jr., MD, PhD; Intan Dewi, MD; Christina Cunha, PhD; Lore vanderBeeke, MD; Martin Jaeger, PhD; Mark Gresnigt, PhD; Agustin Resendiz, PhD; Katrien Lagrou, PhD; Greetje Van De Velde, PhD; Joost Wauters, MD; Agostinho Carvalho, PhD
10:45 AM
Managing Invasive Aspergillosis in the Era of Diagnostic PCR and Increasing Triazole Resistance: a Modelling Study of Different Strategies.
Robert Van De Peppel, MD; Martha Van Der Beek, MD, PhD; Mark De Boer, MD PhD; Jacco Wallinga, Prof. PhD
11:00 AM
GRP78 and Integrin β1/α3 Play Disparate Roles in Epithelium Invasion During Mucormycosis
Abdullah Alqarihi, MS; Teclegiorgis Gebremariam, MS; Sondus Alkhazraji, PhD; Priya Uppuluri, PhD; John E. Edwards, Jr. Jr., MD, FIDSA; Ashraf S. Ibrahim, PhD
11:15 AM
Emerging pathogen Candida auris evades neutrophil attack
Chad Johnson, PhD; J Muse Davis, MD/PhD; Anna Huttenlocher, MD; John Kernien, BS; Jeniel Nett, MD, PhD
11:30 AM
Breakthrough invasive fungal infections (IFI) in acute leukemia (AL) patients receiving antifungal prophylaxis
Anastasia Wasylyshyn, MD; Caroline Castillo, MD; Kathleen A. Linder, MD; Shiwei Zhou, MD; Carol A. Kauffman, MD; Marisa H. Miceli, MD

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.